Objective: To identify adverse events (AEs) associated with Levetiracetam (LEV) in children.
Methods: Databases EMBASE (1974-February 2015) and Medline (1946-February 2015) were searched for articles in which paediatric patients (≤18 years) received LEV treatment for epilepsy. All studies with reports on safety were included.